Apellis Pharmaceuticals shares owned by Octagon Capital Advisors
Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Octagon Capital Advisors
from 13F filings
Historical chart of Octagon Capital Advisors investment in Apellis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Apellis Pharmaceuticals held by Octagon Capital Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apellis Pharmaceuticals by Octagon Capital Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $168M | 2.8M | 59.86 |
| 2023-09-30 | $160M | 4.2M | 38.04 |
| 2023-06-30 | $239M | 2.6M | 91.10 |
| 2023-03-31 | $214M | 3.3M | 65.96 |
| 2022-12-31 | $163M | 3.2M | 51.71 |
| 2022-09-30 | $171M | 2.5M | 68.30 |
| 2022-06-30 | $117M | 2.6M | 45.22 |
| 2022-03-31 | $119M | 2.3M | 50.81 |
| 2021-12-31 | $96M | 2.0M | 47.28 |
| 2021-09-30 | $53M | 1.6M | 32.96 |
| 2021-06-30 | $79M | 1.3M | 63.20 |
| 2021-03-31 | $24M | 548k | 42.91 |
| 2020-12-31 | $31M | 548k | 57.20 |